![Johan Lund](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Johan Lund
Direttore/Membro del Consiglio presso OLINK HOLDING AB
Patrimonio netto: 1 M $ in data 31/05/2024
Posizioni attive di Johan Lund
Società | Posizione | Inizio | Fine |
---|---|---|---|
OLINK HOLDING AB | Direttore/Membro del Consiglio | 01/12/2020 | - |
Independent Dir/Board Member | 01/12/2020 | - | |
Genagon Therapeutics AB
![]() Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Direttore/Membro del Consiglio | 01/05/2019 | - |
Kynexis Medicine Development AB | Amministratore Delegato | 01/08/2018 | - |
Fondatore | 01/08/2018 | - | |
Tcer AB | Direttore/Membro del Consiglio | 01/06/2019 | - |
Aqilion AB
![]() Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Presidente | 12/06/2018 | - |
Neogap Therapeutics AB
![]() Neogap Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Neogap Therapeutics AB is a Swedish clinical stage biopharmaceutical company. The private company is based in Stockholm, Sweden. | Presidente | - | - |
Pelago Bioscience AB
![]() Pelago Bioscience AB Miscellaneous Commercial ServicesCommercial Services Pelago Bioscience AB is a specialized CRO that focuses on their patented cetsa® technology. The private company is based in Solna, Sweden. The technology can be applied throughout all steps of the drug discovery value chain. Pelago Bioscience provides bespoke projects in a wide range of services. The Swedish company's cetsa® navigate enables rapid target engagement confirmation, cetsa® navigate ht is for efficient high-throughput discovery, and cetsa® explore is a mass spectrometry-based approach allowing unbiased proteome-wide investigation. The Pelago Knowledge Center is a collection of resources used to drive innovation in drug discovery focusing on excellence in target engagement. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Johan Lund
Precedenti posizioni note di Johan Lund
Società | Posizione | Inizio | Fine |
---|---|---|---|
CELGENE | Corporate Officer/Principal | 01/03/2016 | 01/05/2017 |
J Lund & Associates, LLC | Corporate Officer/Principal | 01/04/2015 | 01/03/2016 |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Johan Lund
Karolinska Institutet | Doctorate Degree |
Statistiche
Distribuzione geografica
Svezia | 11 |
Stati Uniti | 5 |
Norvegia | 2 |
Posizioni
Corporate Officer/Principal | 6 |
Director/Board Member | 5 |
Independent Dir/Board Member | 2 |
Settori
Health Technology | 6 |
Commercial Services | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
OLINK HOLDING AB | Health Technology |
PFIZER, INC. | Health Technology |
LIDDS AB | Health Technology |
Aziende private | 10 |
---|---|
Genagon Therapeutics AB
![]() Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
Kynexis Medicine Development AB | |
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
J Lund & Associates, LLC | |
Tcer AB | |
Aqilion AB
![]() Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
Neogap Therapeutics AB
![]() Neogap Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Neogap Therapeutics AB is a Swedish clinical stage biopharmaceutical company. The private company is based in Stockholm, Sweden. | Commercial Services |
Pelago Bioscience AB
![]() Pelago Bioscience AB Miscellaneous Commercial ServicesCommercial Services Pelago Bioscience AB is a specialized CRO that focuses on their patented cetsa® technology. The private company is based in Solna, Sweden. The technology can be applied throughout all steps of the drug discovery value chain. Pelago Bioscience provides bespoke projects in a wide range of services. The Swedish company's cetsa® navigate enables rapid target engagement confirmation, cetsa® navigate ht is for efficient high-throughput discovery, and cetsa® explore is a mass spectrometry-based approach allowing unbiased proteome-wide investigation. The Pelago Knowledge Center is a collection of resources used to drive innovation in drug discovery focusing on excellence in target engagement. | Commercial Services |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Harden Pharmacy LLC |
- Borsa valori
- Insiders
- Johan Lund
- Esperienza